Jorge J Castillo

138PUBLICATIONS
278CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (138)

|Jul 08, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.

|May 15, 2026
Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management.

|Mar 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Matthew Hamby, Brian L Egleston, Zachary A K Frosch

|Mar 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Jorge J Castillo, Andrew R Branagan, Alberto Guijosa

|Feb 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Hao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu

|Jan 22, 2026
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia.

Shayna Sarosiek, Jorge J Castillo, Zachary R Hunter

Pageof 23

Frequent Collaborators

58 joint publications

Steven P Treon

31 joint publications

Zachary R Hunter

25 joint publications

Shayna Sarosiek

20 joint publications

Andrew R Branagan